VURALLI BAKKALOĞLU, D. Et Al. 2016. The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.. XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , (Köln, Germany).

VURALLI BAKKALOĞLU, D., ŞENTÜRK ÇİFTÇİ, H., MÜSLÜMANOĞLU, M. E., EKİZOĞLU ERATAK, S., KEKİK ÇINAR, Ç., AR, M. C., ... TÜZÜNER TUNÇAY, N. N.(2016). The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry. . XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology, Köln, Germany

VURALLI BAKKALOĞLU, Doğu Et Al. "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.," XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology, Köln, Germany, 2016

VURALLI BAKKALOĞLU, Doğu V. Et Al. "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.." XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , Köln, Germany, 2016

VURALLI BAKKALOĞLU, D. Et Al. (2016) . "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.." XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , Köln, Germany.

@conferencepaper{conferencepaper, author={Doğu VURALLI BAKKALOĞLU Et Al. }, title={The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.}, congress name={XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology}, city={Köln}, country={Germany}, year={2016}}